Anna Ianza

Trieste, 34129, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Epithelioid Mesothelioma Patients with Very Long Survival Display Defects in DNA Repair.

Epithelioid Mesothelioma Patients with Very Long Survival Display Defects in DNA Repair.

Journal: Cancers

Published: June 28, 2023

Prognostic value of alkaline phosphatase and gamma-glutamyl transferase in patients with metastatic pancreatic cancer.

Prognostic value of alkaline phosphatase and gamma-glutamyl transferase in patients with metastatic pancreatic cancer.

Journal: Future oncology (London, England)

Published: May 26, 2023

EGFR mutation analysis on circulating free DNA in NSCLC: a single-center experience.

EGFR mutation analysis on circulating free DNA in NSCLC: a single-center experience.

Journal: Journal of cancer research and clinical oncology

Published: December 28, 2020

Role of the IGF-1 Axis in Overcoming Resistance in Breast Cancer.

Role of the IGF-1 Axis in Overcoming Resistance in Breast Cancer.

Journal: Frontiers in cell and developmental biology

Published: December 14, 2020

Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study.

Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study.

Journal: Breast cancer research and treatment

Published: June 19, 2020

Association between neutropenia and survival to nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer.

Association between neutropenia and survival to nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer.

Journal: Scientific reports

Published: June 16, 2020

ΔKi67 proliferation index as independent predictive and prognostic factor of outcome in luminal breast cancer: data from neoadjuvant letrozole-based treatment.

ΔKi67 proliferation index as independent predictive and prognostic factor of outcome in luminal breast cancer: data from neoadjuvant letrozole-based treatment.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: June 04, 2020

Clinical Outcomes and Safety of Patients Treated with NAb-Paclitaxel Plus Gemcitabine in Metastatic Pancreatic Cancer: The NAPA Study.

Clinical Outcomes and Safety of Patients Treated with NAb-Paclitaxel Plus Gemcitabine in Metastatic Pancreatic Cancer: The NAPA Study.

Journal: Current cancer drug targets

Published: May 27, 2020

Optimal primary end point in Phase II trials of immune checkpoint inhibitors for advanced solid cancers: an evolving issue.

Optimal primary end point in Phase II trials of immune checkpoint inhibitors for advanced solid cancers: an evolving issue.

Journal: Immunotherapy

Published: February 22, 2019

Tumour infiltrating lymphocytes and PD-L1 expression as potential predictors of outcome in patients with malignant pleural mesothelioma.

Tumour infiltrating lymphocytes and PD-L1 expression as potential predictors of outcome in patients with malignant pleural mesothelioma.

Journal: Molecular biology reports

Published: November 17, 2018

Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer.

Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer.

Journal: Cells

Published: June 05, 2018

Lenvatinib for the treatment of renal cell carcinoma.

Lenvatinib for the treatment of renal cell carcinoma.

Journal: Expert opinion on investigational drugs

Published: May 03, 2018

Showing 1-12 of 17

Last Updated: 09/26/2026